Drug Discovery & Development
Drug Discovery & Development
Kali Therapeutics Receives US FDA Clearance for KT501 Investigational New Drug Application
The US Food and Drug Administration (FDA) has cleared Kali Therapeutics, a clinical-stage biotechnology company pioneering next-generation immune-resetting and multi-specific therapies, Investigational New Drug...
Drug Discovery & Development
Thryv Therapeutics licences a new class of SGK1 inhibitors from Spain’s CSIC and Universidad Autónoma de Madrid, extending its platform into neurodegenerative disease
Thryv Therapeutics has entered into an exclusive, worldwide, royalty-bearing patent and know-how license agreement with the Spanish National Research Council (Consejo Superior de Investigaciones...
Drug Delivery and Supply Chain
Lubrizol targets drug delivery challenges at CPHI Milan
Lubrizol will showcase its portfolio of multifunctional excipients at CPHI Milan (6-8 October), and demonstrate how they solve diverse drug delivery challenges.
Visitors to stand...
Drug Discovery & Development
FairJourney Bio delivers antibody engineering for novel tumour-conditional IL-12 therapeutic approach that unlocks the potential of localised cytokine activation
FairJourney Bio, a global antibody discovery expert, has announced the publication of a peer-reviewed study in mAbs describing a novel approach with the potential to...
Drug Delivery and Supply Chain
Taysha Gene Therapies and Catalent expand strategic partnership to include future commercial manufacturing support of TSHA-102 gene therapy for Rett syndrome
Taysha Gene Therapies, a clinical-stage biotechnology company focused on developing adeno-associated virus (AAV)-based gene therapies for rare, monogenic diseases of the central nervous system,...
Pharma Lab news
Aurisco Pharmaceutical’s Chinese manufacturing plant gets green light from US Food and Drug Administration
Aurisco Pharmaceutical announced that its manufacturing site in Yangzhou, China, has passed a US Food and Drug Administration (USFDA) pre-approval inspection, making it the first...
Drug Discovery & Development
Veeva Vault CRM selected by Eli Lilly and Company
Veeva Systems has announced that Eli Lilly and Company (Lilly) has committed to Veeva Vault CRM globally.
Vault CRM is part of the Vault CRM Suite of applications...
Drug Discovery & Development
Adneuris Therapeutics grants exclusive license to Maruishi Pharmaceutical to advance Cebranopadol in Japan and South Korea
Adneuris Therapeutics has entered into an exclusive license agreement with Maruishi Pharmaceutical Co., Ltd., a privately held, perioperative and pain-focused pharmaceutical company based in...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
